Improvement of Dupilumab‐Induced Psoriasiform Eruption Following a Switch to Tralokinumab
ABSTRACT Biologic therapies have transformed the management of atopic dermatitis (AD) and prurigo nodularis (PN), yet paradoxical adverse events such as dupilumab‐induced psoriasiform eruption (DPE) are increasingly recognized. We report a 48‐year‐old Japanese man with long‐standing AD and PN who de...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Wiley
2025-12-01
|
| Seri Bilgileri: | JEADV Clinical Practice |
| Konular: | |
| Online Erişim: | https://doi.org/10.1002/jvc2.70163 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|